InVivoMAb anti-mouse CD4 BE0003-1 100mg/ea 1 $3,256.05 and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0486515-V2
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $5,556
About this award
Bio X Cell has been awarded a contract by the University of Virginia for the procurement of InVivoMAb monoclonal antibody products. The award, designated A207_PO-0486515-V2, was executed on October 5, 2026, with a cumulative contract value of $5,556.25. The contract encompasses two distinct line items representing specialized immunological research reagents to be delivered to Min Xiang at the University of Virginia's facility in Virginia.
The deliverables consist of InVivoMAb anti-mouse CD4 BE0003-1 (100 milligrams per unit) valued at $3,256.05 and InVivoMAb anti-mouse B220 BE0067 (50 milligrams per unit) valued at $2,300.20, with one unit of each product ordered. These monoclonal antibodies are typically utilized in research applications involving murine immunology and flow cytometry analysis. The contract represents a straightforward procurement transaction for laboratory research materials with no performance period specified beyond the award date.
Line items
| Item | Total |
|---|---|
| InVivoMAb anti-mouse CD4 BE0003-1 100mg/ea 1 $3,256.05 | $3,256.05 |
| InVivoMAb anti-mouse B220 BE0067 50mg/ea 1 $2,300.20 | $2,300.20 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0486515-V2?
Contract A207_PO-0486515-V2 was awarded to Bio X Cell by University of Virginia on October 5, 2026.
How much is contract A207_PO-0486515-V2 worth?
Its cumulative value is $5,556.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award